Related Experiment Video
Updated: Mar 28, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
microRNA and Chronic Lymphocytic Leukemia
Dana Elena Giza1,2, George A Calin3,4
1Experimental Therapeutics Department, The University of Texas MD Anderson Cancer Center, Unit 1950, 1515 Holcombe Blvd, Houston, TX, 77030-4009, USA. DEGiza@mdanderson.org.
Abstract:
Expression profiling of microRNAs identified important differences in microRNA expression between CLL samples and normal CD5+ B-cells. Researchers have first discussed the dual role of miRNAs working as tumor suppressors (inhibiting malignant potential) or as oncogenes (activating malignant potential) in CLL pathogenesis. Understanding the roles of miRNAs in leukemic cells brings information on a new layer of gene regulation and also provides new markers for improved diagnosis and prognosis, as well as novel therapeutic options for CLL patients. Herein we will focus on the roles of miRNAs in CLL, highlighting what is already known about their function, proposing a novel model of CLL predisposition and progression, and describing the challenges for the near future.
Insights
MicroRNA expression differs between chronic lymphocytic leukemia (CLL) and normal B-cells, revealing their dual role in cancer. This research offers new diagnostic and therapeutic strategies for CLL patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) play a critical role in cellular processes.
- Dysregulation of miRNAs is implicated in various cancers, including chronic lymphocytic leukemia (CLL).
- Understanding miRNA roles in CLL pathogenesis is crucial for advancing treatment.
Purpose of the Study:
- To investigate the differential expression of miRNAs in CLL samples compared to normal CD5+ B-cells.
- To elucidate the dual role of miRNAs as tumor suppressors or oncogenes in CLL.
- To propose a novel model for CLL predisposition and progression.
Main Methods:
- Expression profiling of microRNAs in CLL and normal B-cell samples.
- Analysis of miRNA roles in leukemic cell function.
- Literature review and data synthesis to propose a novel model.
Main Results:
- Significant differences in miRNA expression were identified between CLL and normal CD5+ B-cells.
- miRNAs exhibit a dual role in CLL, acting as either tumor suppressors or oncogenes.
- This understanding provides insights into a new layer of gene regulation in CLL.
Conclusions:
- Altered miRNA expression is a key feature of CLL.
- miRNAs offer potential as diagnostic markers and therapeutic targets for CLL.
- Further research is needed to fully understand miRNA functions and challenges in CLL treatment.
More Related Videos
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons